期刊文献+

柚皮苷-羟丙基-β-环糊精包合物酶解制备柚皮素工艺的研究 被引量:5

Preparation of naringenin by enzymolysis of naringin-HP-β-CD
原文传递
导出
摘要 目的:确定羟丙基-β-环糊精包合柚皮苷后酶解制备柚皮素的主要因素,并优选出高转化效率、稳定、适合工业化生产的工艺条件。方法:采用逐步滴加法制备柚皮苷-羟丙基-β-环糊精包合物,并利用蜗牛酶将其水解制备柚皮素,以转化率为指标,通过单因素考察pH、温度、反应时间、酶用量及底物浓度对转化率的影响,并通过正交试验优化其制备工艺;采用差示扫描量热法验证柚皮苷是否被羟丙基-β-环糊精包合,采用1H-NMR,13C-NMR鉴定水解产物。结果:柚皮苷-羟丙基-β-环糊精包合物在最佳酶解条件下(温度37℃、pH 5.0、底物质量浓度30 g.L-1,酶与底物比3∶5,反应时间12 h)的转化率为98.4%,远大于未包合柚皮苷的转化效率;反应产物相对分子质量为272.25,核磁共振谱证实产物为柚皮素。结论:柚皮苷经羟丙基-β-环糊精包合后酶解制备柚皮素,可以缩短反应时间、提高底物浓度、减少酶用量,从而显著提高转化效率。该工艺稳定,适合工业化生产。 Objective: To determine the major factors affecting the conversion efficiency of naringin-HP-β-CD that was en- zymed to prepare naringenin were determined and select the process condition with high conversion efficiency, stable and suitable for industrial production. Method: The dropping method was used to prepare naringin-HP-β-CD, which was hydrolyzed by snailase to obtain naringenin. With the bioconversion rate as the index, the effects of pH value, temperature, reaction time, dosage of enzyme and concentration of naringin-HP-β-CD on conversion rate of naringenin were detected for the purpose of optimizing the preparation condition. the conversion efficiency of naringin-HP-β-CD was verified by scanning calorimetry, and the Hydrolysis product was identified by 1H-NMR, and t3C_NMR. Result: The optimum enzymolysis of naringin-HP-β-CD with snailase was 98.4% under the conditions of 37 ℃, a pH 5.0 acetic acid- sodium acetate buffer solution for 12 hours. The substrate concentration was 30 g·L-1 and the weight ratio of enzyme and substrate was 3:5. Under the optimum enzymolysis condition, the conversion rate of naringin-HP-β-CD was higher than naringin that was not entrapped with HP-β-CD, with 272.25 reaction product relative molecules. The structure of nalingenin was con- firmed by the analysis of 1H-NMR and 13 C-NMR. Conclusion: Naringin which is entrapped with HP-β-CD to prepare naringenin can significantly improve the conversion efficiency by shortening the reaction time, increasing the concentration of the substrate and reduc- ing the amount of enzyme. Therefore, the process is stable and it was suitable for industrialization.
出处 《中国中药杂志》 CAS CSCD 北大核心 2012年第3期310-314,共5页 China Journal of Chinese Materia Medica
基金 江苏省医药高技术计划项目(BG2007614)
关键词 转化效率 羟丙基-Β-环糊精 柚皮苷 柚皮素 conversion efficiency hydroxypropyl-β-cyclodextrin naringin naringenin
  • 相关文献

参考文献17

  • 1Ruh M F, Zacharewski T, Connor K, et al. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity[J]. Biochem Pharnmcol, 1995, 50: 1485.
  • 2So F V, Guthrie N, Chambers A F, et al. Carroll, Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices [ J ]. Nutr Cancer, 1996, 26 : 167.
  • 3van Aeker F A, Schouten O, Haenen G R, et al. Flavonoids can replace alpha-tocopherol as an antioxidant [ J ]. FEBS Lett, 2000, 473 : 145.
  • 4Santos K F, Oliveira T T, Nagem T J, et al, Hypolipidaemic effects of naringenin, rutin, nicotinic acid and their associations [J]. Pharmacol Res, 1999, 40:493.
  • 5Lee S H, Park Y B, Bae K H, et al. Cholesterot-lowerlng activity of naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl eoenzyme A: cholesterol aeyltransferase in rats[J]. Ann Nutr Metab, 1999, 43:173.
  • 6Borradaile N M, Carroll K K, Kurowska E M. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin [J]. Lipids, 1999, 34:591.
  • 7Guengerich F P, Kim D H. In vitro inhibition of dihydropyridine oxidation and aflatoxin BI activation in human liver microsomes by naringenin and other flavonoids[ J]. Carcinogenesis, 1990, 11:2275.
  • 8Ping C H, Dorothy J S, Peter F C, et al. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products [ J ]. Pharma Acta Helv, 2000, 74:379.
  • 9何仲贵,唐星,陈宣福,张汝华,张天虹,宋志军.β-环糊精及其衍生物2-羟丙基β-环糊精对布洛芬的增溶作用[J].沈阳药科大学学报,1998,15(4):235-237. 被引量:33
  • 10陶涛.羟丙基倍他环糊精的特性及其药剂学应用[J].中国医药工业杂志,2002,33(6):304-308. 被引量:87

二级参考文献24

  • 1丁平田,吴雪梅.药物制剂的新型辅料2-羟丙基-β-环糊精[J].国外医药(合成药.生化药.制剂分册),1996,17(2):107-111. 被引量:62
  • 2周兴旺,徐国钧,王强.地骨皮化学成分的研究[J].中国中药杂志,1996,21(11):675-676. 被引量:27
  • 3惠军,吴焱,祝长青.新疆蜗牛酶的研制[J].新疆师范大学学报(自然科学版),2006,25(3):90-92. 被引量:8
  • 4王敏,高锦明,王军,王丽云.苦荞茎叶粉中总黄酮酶法提取工艺研究[J].中草药,2006,37(11):1645-1648. 被引量:50
  • 5江苏新医学院.中药大辞典[M].上海:上海科学技术出版社,1995.1976.
  • 6于德泉 杨峻山.分析化学手册 ,第七分册.第2版[M].北京:化学工业出版社,1999.844.449.
  • 7The Sadtler Standard Spectra[J].Standard N M R Spectra,1971,:16-18,1040.
  • 8Huang J, Yuan L, Wang X, et al, Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro[ J]. Life Sci ,2007,81 (10) :832.
  • 9Kyung Young Yoon, Myeonghwa Cha, Seung Ryeul Shin,et al. Enzymatic production of a soluble-fibre hydrolyzate from carrot poreace and its sugar composition [ J]. Food Chemistry, 2005,92: 151.
  • 10Huang J, Yuan L, Wang X, et al. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro [J]. Life Sci, 2007, 81 (10):832-840.

共引文献248

同被引文献43

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部